Home

FOR ADVANCED THERAPEUTICS

HIGH PERFORMANCE CELL TECHNOLOGIES

WITH CEVEC ACQUISITION

CELL LINE DEVELOPMENT

CYTIVA STRENGTHENS

CEVEC is a leading provider of high-performance cell technology for the manufacturing of advanced bio-therapeutics from R&D to manufacturing scale. The company’s product portfolio comprises various platform technologies for gene therapy vectors, vector vaccines and complex recombinant proteins.

In the viral vector space, ELEVECTA™ is the technology of choice for AAV manufacturing. For RCA-free Adenoviral vectors, the CAP™ Ad Technology is the perfect fit. CAP™ Go is the solution to enable the production of complex and highly glycosylated recombinant proteins.

STABLE AAV PRODUCER CELL LINES

RCA-FREE ADENOVIRAL VECTORS

GLYCO-OPTIMIZED PROTEINS

CELL & GENE THERAPY MANUFACTURING & COMMERCIALIZATON

Boston, USA
09/18/2023 – 09/21/2023

TO THE MEETING

OPEN POSITIONS

FOR OPEN POSITIONS BASED IN THE CEVEC OFFICE IN COLOGNE,
PLEASE CLICK

HERE

KEEP IN TOUCH

By clicking any of these options and submitting this form, you agree to receive marketing emails, newsletters and other promotional communications from Cytiva. You can withdraw your consent at any time, by clicking here. For more information please review our privacy policy.